Friends of ANCHOR has seen waiting lists reduced by up to 50% for North-east cancer patients following our investment into new equipment for the gastroenterology department at ARI.
The recent funding of £32,000 equipped the department with two additional neonatal endoscopes. Previously the department only had access to one such endoscope and was unable to meet their target referral time of one to two weeks.
With the arrival of the two additional neonatal endoscopes, the gastroenterology medical team are able to carry out procedures to keep up with demand and most importantly the investment enables them to offer quicker referral and treatment for cancer patients.
The number of patients being referred for gastropexy insertion has increased by 150% since 2013. The rise in referrals is determined by a greater recognition that better nutritional care for patients is crucial during their cancer journey. Previously, patients on the referral list have had to wait up to three weeks for the neononatal endoscopic procedure, causing potential delays in starting their cancer treatment.
The neonatal equipment significantly enhances the provision and accessibility of improved nutritional care for patients in Grampian. The endoscopes enable the highly accurate placement of a gastrostomy tube directly into the stomach to help cancer patients who are unable to take in adequate amounts of hydration and nutrition by mouth.
Dr Emma Metcalfe from the Department of Gastroenterology, comments; “Nutrition is an increasingly recognised crucial aspect of health care. The subsequent increase in referrals for gastropexy insertion over the past few years has put huge pressure on the department’s capacity to perform the procedure within our one to two week target window. With access to just one neonatal endoscope, we were unable to meet the rising demand for the procedures requiring the equipment.
“For cancer patients, these procedures help support their basic requirements of hydration and nutrition during their treatment and in their palliative paths. This equipment will significantly benefit patients with upper gastrointestinal, head and neck, and lung/mediastinal malignancies in Grampian.
“To have access to funding from Friends of ANCHOR is crucial in providing the best quality care and support for our patients. Without the generous support, the department simply would not be able to afford this much-needed investment. With the additional two neonatal endoscopes, we are able to plan ahead more effectively and have confidence that we are able to keep up with the increasing demand of our services.”
Friends of ANCHOR‘s investment, to improve nutrition for cancer patients, is part of the charity’s ongoing commitment to funding medical equipment that is over and above what NHS Grampian can provide.
Our Vice Chairman, Andrew Hutcheon, comments; “The demand on the gastroenterology is increasing year-on-year. The funding for this equipment was an easy decision for us as a committee as it’s 100% in line with our commitment to provide the best quality treatment, care and support for cancer patients in the North-East of Scotland.
For Dr Metcalfe and her team to have access to additional neonatal endoscopes is hugely beneficial in keeping up with the growing demand for this procedure. To have additional specialist medical equipment for a department that is striving for excellence for their patients is something to celebrate in terms of leading the way in cancer treatment and care.
“We are incredibly grateful to our donors at Friends of ANCHOR who enable the charity to provide this level of investment and support.”
As well as investing in medical equipment, we provide funding for cancer patient wellbeing services and initiatives as well as investment in ground-breaking cancer research projects led by top clinicians at the University of Aberdeen. Every single penny donated to the charity goes directly to the cause as all the administration costs are fully covered by Balmoral Group.